Latest Cleveland Clinic Stories
Effective today, joint venture is now fully operational LAS VEGAS, May 1, 2013 /PRNewswire/ -- Cleveland Clinic and VHA have unveiled the name of their new company: Excelerate Strategic Health Sourcing. The name comes three months after both organizations announced the joint venture, which is fully operational beginning today. Excelerate is a unique provider-led model that brings evidence-based clinical outcomes to product decision making. Incorporating physician integration,...
Ongoing effort shows promise in reducing stress in the workplace through cost-effective online tools The use of Internet-based stress management programs (ISM) effectively reduce stress for a sustainable period, according to a Cleveland Clinic study published recently in Annals of Behavioral Medicine. Online stress management programs aim to increase accessibility for individuals affected by chronic stress at a lesser cost than traditional methods. Data suggests that stress reduction...
Clinical study in over 4,000 subjects finds blood TMAO levels linked to increased risk of heart disease, even in the absence of known cardiovascular risks A microbial byproduct of intestinal bacteria contributes to heart disease and serves as an accurate screening tool for predicting future risks of heart attack, stroke and death in persons not otherwise identified by traditional risk factors and blood tests, according to Cleveland Clinic research published today in The New England Journal...
CHICAGO, April 15, 2013 /PRNewswire-iReach/ -- Becker's Hospital Review Names 100 Great Hospitals in America Becker's Hospital Review has published its annual list, "100 Great Hospitals in America." This year's list provides a glimpse into our country's diverse hospital landscape, from hospitals established within the past decade to those dating back to the 18th century. Be they academic medical centers, community hospitals, large flagship facilities or small specialty hospitals,...
Dr. Stephen Nicholls named as Chair of Clinical Advisory Board IRVINE, Calif., April 11, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Stephen Nicholls, M.B.B.S., PhD., Heart Disease Theme leader at the South Australia Health and Medical Research Institute (SAHMRI), has been appointed as chair of the newly...
Despite comparable pre-surgery risk scores, patients with radiation heart disease found to be at much greater risk years after surgery Patients who have open heart surgery for heart disease caused by radiation cancer treatment are nearly twice as likely to die in the years following their surgery compared to similar patients who did not undergo radiation treatment, according to new research from Cleveland Clinic published today in the American Heart Association journal Circulation. The...
Text-to-donate campaign added to Keep Memory Alive's fundraiser in Las Vegas on April 13 LAS VEGAS, March 25, 2013 /PRNewswire/-- Keep Memory Alive's 17(th) annual Power of Love Gala continues to grow with an extended list of entertainment icons and celebrities attending and performing at the 80(th) birthday celebration for Quincy Jones and Sir Michael Caine in Las Vegas. The star-studded tribute will take place on April 13, 2013, at MGM Grand Hotel & Casino, while raising funds...
NASHVILLE, Tenn., March 19, 2013 /PRNewswire/ -- The first two installations of Apoteca in the United States took place at the Cleveland Clinic and Wake Forest University Baptist Medical Center. Cleveland Clinic's implementation plan included a lengthy review and approval by the Ohio Board of Pharmacy. Both facilities deployed Apoteca in busy oncology centers serving both inpatients and outpatients. Daily production includes complex doses that require reconstitution, multiple vials,...
Collaboration between Leading Healthcare Providers Focuses on Clinical Quality, Access and Affordable Care CLEVELAND and FRANKLIN, Tenn., March 11, 2013 /PRNewswire/ -- Community Health Systems (NYSE: CYH) and Cleveland Clinic have formed a strategic alliance to enhance the quality of patient care, improve access to healthcare services, reduce costs and drive operational excellence. In this period of dynamic change in healthcare, Cleveland Clinic and Community Health Systems...
Phase 3 findings published in NEJM provide answers about treatment with darbepoetin alfa Researchers from Cleveland Clinic and Sweden-based Sahlgrenska University Hospital have found that a commonly used drug to treat anemia in heart failure patients –darbepoetin alfa – does not improve patients' health, nor does it reduce their risk of death from heart failure. Results of the international study were presented at the American College of Cardiology's annual meeting in San Francisco...
